6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Purity ≥98.0% (HPLC) Favipiravir Intermediate COVID-19

Katerangan pondok:

Ngaran Kimia: 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile

6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile

CAS: 356783-31-8

Penampilan: Bulak Konéng nepi Bubuk Pareum-Bodas

Purity: ≥98.0% (HPLC)

Panganteur Favipiravir (CAS: 259793-96-9) dina pengobatan inféksi virus Influenza sareng COVID-19

Kualitas luhur, Produksi komérsial

Inquiry: alvin@ruifuchem.com

Kirim surélék ka kami

Rincian produk

Produk patali

Tag produk

Katerangan:

Produsén kalawan Purity High sarta Quality Stabil
Pasokan Komersial Favipiravir sareng Perantara Patali:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Dietil Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Sipat Kimia:

Ngaran Kimia	6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile
sinonim	6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile
Nomer CAS	356783-31-8
Nomer CAT	RF-API294
Status saham	Dina Stok, Skala Produksi Nepi ka Ratusan Kilogram
Formula Molekul	C5H2FN3O
Beurat Molekul	139.09
merek	Kimia Ruifu

spésifikasi:

Barang	spésifikasi
Penampilan	Bubuk Konéng nepi Pareum-Bodas
Idéntifikasi	IR, HPLC
Kelembapan (KF)	≤1,0%
Résidu on Ignition	≤0,50%
Najis Tunggal	≤1,0%
Total Kotoran	≤2,0%
Logam beurat	≤20ppm
Kasucian	≥98.0% (ku HPLC)
Standar tés	Standar Perusahaan
Pamakéan	Panganteur Favipiravir (CAS 259793-96-9);Antiviral;COVID 19

Paket & Panyimpenan:

Bungkusan: Botol, kantong Aluminium foil, kardus drum, 25kg / Drum, atawa nurutkeun sarat customer urang.

Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya, Uap jeung infestation hama.

Kaunggulan:

FAQ:

Aplikasi:

6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) mangrupikeun Perantara Favipiravir (CAS 259793-96-9).Favipiravir mangrupikeun ubar antiviral spéktrum lega énggal anu nargétkeun RNA-dependent RNA polymerase (RdRp).Favipiravir mimitina dikembangkeun dina ahir taun 1990-an ku perusahaan anu engkéna dibeuli ku firma Jepang Fujifilm salaku bagian tina transisi tina bisnis poto ka kasehatan.Sanggeus diuji ngalawan sauntuyan virus, ubar ieu disatujuan di Jepang dina 2014 pikeun pamakéan darurat ngalawan epidemics flu atawa pikeun ngubaran galur anyar influenza.Salila wabah koronavirus anyar, hasil studi klinis Fase I ngeunaan ubar anu diterbitkeun dina Maret 2020 nunjukkeun yén ubar éta tiasa gaduh pangaruh nyepetkeun pembersihan virus pikeun ngirangan kamajuan pneumonia coronavirus anyar.Favipiravir tiasa dianggo dina pengobatan pasien COVID-19 anu disarankeun ku WHO.Dibersihkeun ku Drugs Controller General of India (DCGI) pikeun panggunaan "darurat dibatesan" di antara pasien COVID-19.